169 related articles for article (PubMed ID: 34675939)
1. Expression Regulation and Function of T-Bet in NK Cells.
Huang C; Bi J
Front Immunol; 2021; 12():761920. PubMed ID: 34675939
[TBL] [Abstract][Full Text] [Related]
2. Sequential actions of EOMES and T-BET promote stepwise maturation of natural killer cells.
Zhang J; Le Gras S; Pouxvielh K; Faure F; Fallone L; Kern N; Moreews M; Mathieu AL; Schneider R; Marliac Q; Jung M; Berton A; Hayek S; Vidalain PO; Marçais A; Dodard G; Dejean A; Brossay L; Ghavi-Helm Y; Walzer T
Nat Commun; 2021 Sep; 12(1):5446. PubMed ID: 34521844
[TBL] [Abstract][Full Text] [Related]
3. T-BET and EOMES sustain mature human NK cell identity and antitumor function.
Wong P; Foltz JA; Chang L; Neal CC; Yao T; Cubitt CC; Tran J; Kersting-Schadek S; Palakurty S; Jaeger N; Russler-Germain DA; Marin ND; Gang M; Wagner JA; Zhou AY; Jacobs MT; Foster M; Schappe T; Marsala L; McClain E; Pence P; Becker-Hapak M; Fisk B; Petti AA; Griffith OL; Griffith M; Berrien-Elliott MM; Fehniger TA
J Clin Invest; 2023 Jul; 133(13):. PubMed ID: 37279078
[TBL] [Abstract][Full Text] [Related]
4. Strategies to enhance NK cell function for the treatment of tumors and infections.
Freund-Brown J; Chirino L; Kambayashi T
Crit Rev Immunol; 2018; 38(2):105-130. PubMed ID: 29953390
[TBL] [Abstract][Full Text] [Related]
5. The IL-15-AKT-XBP1s signaling pathway contributes to effector functions and survival in human NK cells.
Wang Y; Zhang Y; Yi P; Dong W; Nalin AP; Zhang J; Zhu Z; Chen L; Benson DM; Mundy-Bosse BL; Freud AG; Caligiuri MA; Yu J
Nat Immunol; 2019 Jan; 20(1):10-17. PubMed ID: 30538328
[TBL] [Abstract][Full Text] [Related]
6. [Roles of interleukin-21 and its receptor in autoimmune diseases].
Yang DJ; Han B
Zhongguo Dang Dai Er Ke Za Zhi; 2016 May; 18(5):466-71. PubMed ID: 27165599
[TBL] [Abstract][Full Text] [Related]
7. Immunoregulatory natural killer cells.
Roe K
Clin Chim Acta; 2024 May; 558():117896. PubMed ID: 38583553
[TBL] [Abstract][Full Text] [Related]
8. Eomesodermin spatiotemporally orchestrates the early and late stages of NK cell development by targeting KLF2 and T-bet, respectively.
He J; Chen D; Xiong W; Hou X; Quan Y; Yang M; Dong Z
Cell Mol Immunol; 2024 May; ():. PubMed ID: 38740922
[TBL] [Abstract][Full Text] [Related]
9. DNA demethylase Tet2 promotes the terminal maturation of natural killer cells.
Lin Y; Yang B; Liu H; Ran G; Song L; Meng M; Yin X; Bi Q; Yan D; Deng Y; Lu Y
Immunol Res; 2024 Jun; ():. PubMed ID: 38869819
[TBL] [Abstract][Full Text] [Related]
10. Differential regulation of transcription factor T-bet induction during NK cell development and T helper-1 cell differentiation.
Fang D; Cui K; Cao Y; Zheng M; Kawabe T; Hu G; Khillan JS; Li D; Zhong C; Jankovic D; Sher A; Zhao K; Zhu J
Immunity; 2022 Apr; 55(4):639-655.e7. PubMed ID: 35381213
[TBL] [Abstract][Full Text] [Related]
11. The hTERT and iCasp9 Transgenes Affect EOMES and T-BET Levels in NK Cells and the Introduction of Both Genes Improves NK Cell Proliferation in Response to IL2 and IL15 Stimulation.
Palamarchuk AI; Kovalenko EI; Streltsova MA
Biomedicines; 2024 Mar; 12(3):. PubMed ID: 38540262
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus: the mastermind of immune chaos.
Silva JM; Alves CEC; Pontes GS
Front Immunol; 2024; 15():1297994. PubMed ID: 38384471
[TBL] [Abstract][Full Text] [Related]
13. Diverse modulatory effects of bibenzyls from Dendrobium species on human immune cell responses under inflammatory conditions.
Kongkatitham V; Dehlinger A; Chaotham C; Likhitwitayawuid K; Böttcher C; Sritularak B
PLoS One; 2024; 19(2):e0292366. PubMed ID: 38300920
[TBL] [Abstract][Full Text] [Related]
14. Effective intravenous delivery of adenovirus armed with TNFα and IL-2 improves anti-PD-1 checkpoint blockade in non-small cell lung cancer.
Kudling TV; Clubb JHA; Pakola S; Quixabeira DCA; Lähdeniemi IAK; Heiniö C; Arias V; Havunen R; Cervera-Carrascon V; Santos JM; Sutinen E; Räsänen J; Borenius K; Mäyränpää MI; Aaltonen E; Sorsa S; Hemminki O; Kanerva A; Verschuren EW; Ilonen I; Hemminki A
Oncoimmunology; 2023; 12(1):2241710. PubMed ID: 37546696
[TBL] [Abstract][Full Text] [Related]
15.
Ford SL; Buus TB; Nastasi C; Geisler C; Bonefeld CM; Ødum N; Woetmann A
Front Immunol; 2023; 14():1210836. PubMed ID: 37520551
[TBL] [Abstract][Full Text] [Related]
16. Defining the role of natural killer cells in COVID-19.
Lee MJ; Blish CA
Nat Immunol; 2023 Oct; 24(10):1628-1638. PubMed ID: 37460639
[TBL] [Abstract][Full Text] [Related]
17. The macrophage infectivity potentiator of
Ait Djebbara S; Mcheik S; Percier P; Segueni N; Poncelet A; Truyens C
Front Immunol; 2023; 14():1180900. PubMed ID: 37304288
[TBL] [Abstract][Full Text] [Related]
18. TBX21 attenuates colorectal cancer progression via an ARHGAP29/RSK/GSK3β dependent manner.
Jiang X; Du W; Yang C; Wang S; Li Y; Shen X; Yang X; Yao J; Du R; Zhang X; Huang Y; Shen W
Cell Oncol (Dordr); 2023 Oct; 46(5):1269-1283. PubMed ID: 37067748
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional control of ILC identity.
Korchagina AA; Shein SA; Koroleva E; Tumanov AV
Front Immunol; 2023; 14():1146077. PubMed ID: 36969171
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
